NK killing of E1A-positive tumor target cells requires killer cell receptor interactions with NKG2D ligands in both human (MIC-A/MIC-B, ULBP) and murine tumor cell lines (RAE-1)6. The gene discussed is KLRK1; the disease is neoplasm.